InBrain Neuroelectronics SL

INBRAIN Neuroelectronics is a spin-off company of the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and ICREA. It was established in 2019, at the intersection between MedTech, DeepTech and Digital Health, with a mission to decode brain signals to devise medical solutions for patients with epilepsy, Parkinson’s disease and other neurological disorders. The company designs small implantable brain intelligent systems, with the ability to interpret brain signals with unprecedented high fidelity, producing a therapeutic response adapted to the clinical condition of each specific patient. INBRAIN technology is based on graphene neural interfaces with the capability of reading brain activity at a very high resolution, as well as detecting therapy-specific biomarkers and triggering highly focal adaptive neuromodulation.